Skip to main content
HR 2466 116th Congress House Health Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health care coverage and access Health care quality Health programs administration and funding Health promotion and preventive care Prescription drugs State and local government operations

State Opioid Response Grant Authorization Act of 2020

Introduced: May 1, 2019 See on congress.gov
 Everywhere this bill has been 14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 17, 2020
Considered under suspension of the rules. (consideration: CR H5809-5811)
Nov 17, 2020
Motion to reconsider laid on the table Agreed to without objection.
Nov 17, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5809-5810)
Nov 17, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5809-5810)
Nov 17, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 2466.
Nov 17, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 12, 2020
Placed on the Union Calendar, Calendar No. 466.
Nov 12, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-568.
Sep 9, 2020
Ordered to be Reported by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
May 2, 2019
Referred to the Subcommittee on Health.
May 1, 2019
Referred to the House Committee on Energy and Commerce.
May 1, 2019
Introduced in House
 Plain-English summary Congressional Research Service

State Opioid Response Grant Authorization Act of 2020

This bill reauthorizes through FY2026 and expands the scope of the State Opioid Response Grant program that is administered by the Substance Abuse and Mental Health Services Administration. Current law limits the use of these grants to specifically address the opioid crisis and opioid use disorders, while this bill allows the grants to address substance use disorders more broadly.

What's happening now November 18, 2020

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3
 Cosponsors 34
D
Johnson, Henry C. "Hank"
Georgia · May 1, 2020
D
Luján, Ben Ray
New Mexico · Mar 3, 2020
D
Schrier, Kim
Washington · Dec 19, 2019
D
Brownley, Julia
California · Dec 9, 2019
D
Hayes, Jahana
Connecticut · Dec 3, 2019
R
Baird, James R.
Indiana · Nov 21, 2019
D
Kim, Andy
New Jersey · Oct 21, 2019
D
Crow, Jason
Colorado · Sep 24, 2019
D
Neguse, Joe
Colorado · Sep 19, 2019
D
Doggett, Lloyd
Texas · Sep 10, 2019
D
Tlaib, Rashida
Michigan · Sep 10, 2019
D
Harder, Josh
California · Jul 25, 2019
D
McGovern, James P.
Massachusetts · Jun 18, 2019
D
Slotkin, Elissa
Michigan · Jun 13, 2019
D
Case, Ed
Hawaii · Jun 10, 2019
D
Pappas, Chris
New Hampshire · Jun 10, 2019
D
Scanlon, Mary Gay
Pennsylvania · Jun 10, 2019
D
Houlahan, Chrissy
Pennsylvania · May 30, 2019
D
Craig, Angie
Minnesota · May 21, 2019
D
Foster, Bill
Illinois · May 21, 2019
D
Krishnamoorthi, Raja
Illinois · May 21, 2019
D
Morelle, Joseph D.
New York · May 21, 2019
D
Norton, Eleanor Holmes
District of Columbia · May 21, 2019
D
Raskin, Jamie
Maryland · May 21, 2019
R
Reschenthaler, Guy
Pennsylvania · May 21, 2019
D
Stevens, Haley M.
Michigan · May 21, 2019
D
Trahan, Lori
Massachusetts · May 21, 2019
R
Burchett, Tim
Tennessee · May 14, 2019
D
Dean, Madeleine
Pennsylvania · May 14, 2019
D
Garcia, Sylvia R.
Texas · May 14, 2019
D
Jayapal, Pramila
Washington · May 14, 2019
D
Lee, Susie
Nevada · May 14, 2019
D
McBath, Lucy
Georgia · May 14, 2019
D
Veasey, Marc A.
Texas · May 14, 2019